Frank J Lowery

9PUBLICATIONS
56CO-AUTHORS
Molecular targetsGene and molecular therapyHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 18, 2025
Identification of HLA class II-restricted T cell receptors against shared PIK3CA mutations in patients with epithelial cancers.

S M Rafiqul Islam, Samantha Seitter, Maria Parkhurst

|Oct 15, 2025
Facts and Hopes for Neoantigen-Enriched TIL.

Siqi C Brough, Kristen L Skonieczny, Stav Leibou

|Jan 12, 2025
Utilization of primary tumor samples for cancer neoantigen discovery.

Vid Leko, Eric Groh, Shoshana T Levi

|May 30, 2024
Neoantigen-specific stimulation of tumor-infiltrating lymphocytes enables effective TCR isolation and expansion while preserving stem-like memory phenotypes.

Noam Levin, Sanghyun P Kim, Charles A Marquardt

|May 31, 2023
Cell surface marker-based capture of neoantigen-reactive CD8+ T-cell receptors from metastatic tumor digests.

Praveen D Chatani, Frank J Lowery, Neilesh B Parikh

|Jun 24, 2022
Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors.

Sanghyun P Kim, Nolan R Vale, Nikolaos Zacharakis

Pageof 2

Frequent Collaborators

8 joint publications

Paul Robbins

7 joint publications

Stephanie L Goff

6 joint publications

Sri Krishna

6 joint publications

Sanghyun Peter Kim